Cargando…
A novel combinatorial treatment option for metastatic uveal melanoma
Uveal melanoma (UM) is the most frequent intraocular tumor in adult patients. When metastases occur, systemic therapy with alkylating agents (fotemustine or dacarbazine (DTIC)) has shown only modest efficacy. The common chemotherapeutic drug doxorubicin (DOX) is not used to treat metastatic UM (mUM)...
Autores principales: | Shneor, Dudi, Tayeb, Shay, Pe'er, Jacob, Voropaev, Hanna, Gimmelshein, Maria, Cassoux, Nathalie, Honigman, Alik, Frenkel, Shahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995237/ https://www.ncbi.nlm.nih.gov/pubmed/29899845 http://dx.doi.org/10.18632/oncotarget.25445 |
Ejemplares similares
-
Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma
por: Voropaev, Hanna, et al.
Publicado: (2019) -
Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma
por: Shneor, D, et al.
Publicado: (2017) -
Irreversible Electroporation of Human Primary Uveal Melanoma in Enucleated Eyes
por: Mandel, Yossi, et al.
Publicado: (2013) -
Choroidal Metastasis of Adenocarcinoma of the Lung Presenting as Pigmented Choroidal Tumor
por: Frenkel, Shahar, et al.
Publicado: (2012) -
Upcoming translational challenges for uveal melanoma
por: Nabil, Amirouchene-Angelozzi, et al.
Publicado: (2015)